OSI PHARMACEUTICALS, INC. for OSI PHARMACEUTICALS, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of tax on pharmaceutical manufacturers - Patient Protection and Affordable Care Act (HR 3590/PL 111-148) and Health Care and Education Reconciliation Act of 2010 (HR 4872/PL 111-152)
Foreign entity interest: OSI Pharmaceuticals was recently acquired by Astellas Pharma Inc. Accordingly, Astellas Pharma, Inc, as OSI's owner, has an interest as a pharmaceutical company in all of the issues with respect to which OSI has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LINTHICUM | Leg Dir, Rep Bob Franks (1997-2000), Leg Corr, Rep Charles Taylor (1997), Leg Corr, Rep Bill Martini (1995-1996) |
Health Issues HCR
Health care reform implementation - Patient Protection and Affordable Care Act (HR 3590/PL 111-148) and Health Care and Education Reconciliation Act of 2010 (HR 4872/PL 111-152)
Foreign entity interest: OSI Pharmaceuticals was recently acquired by Astellas Pharma Inc. Accordingly, Astellas Pharma, Inc, as OSI's owner, has an interest as a pharmaceutical company in all of the issues with respect to which OSI has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LINTHICUM | Leg Director, Rep Bob Franks (1997-2000), Leg Correspondent, Rep Charles Taylor (1997), Leg Correspondent, Rep Bill Martini (1995-1996) |
Copyright/Patent/Trademark CPT
Patent settlement arrangements - American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)
Foreign entity interest: OSI Pharmaceuticals was recently acquired by Astellas Pharma Inc. Accordingly, Astellas Pharma, Inc, as OSI's owner, has an interest as a pharmaceutical company in all of the issues with respect to which OSI has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LINTHICUM | Leg Dir, Rep Bob Franks (1997-2000), Leg Corr, Rep Charles Taylor (1997), Leg Corr, Rep Bill Martini (1995-1996) |
Medicare/Medicaid MMM
Medicare Part D coverage gap implementation, implementation of Medicaid rebate increases & expansions - Patient Protection and Affordable Care Act (HR 3590/PL 111-148) and Health Care and Education Reconciliation Act of 2010 (HR 4872/PL 111-152)
Foreign entity interest: OSI Pharmaceuticals was recently acquired by Astellas Pharma Inc. Accordingly, Astellas Pharma, Inc, as OSI's owner, has an interest as a pharmaceutical company in all of the issues with respect to which OSI has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LINTHICUM | Leg Director, Rep Bob Franks (1997-2000), Leg Correspondent, Rep Charles Taylor (1997), Leg Correspondent, Rep Bill Martini (1995-1996) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTELLAS PHARMA INC. | Japan | Japan | 99.9% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.